Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-12-12
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 240
- Registration Number
- NCT06167291
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.
- First Posted Date
- 2023-12-08
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT06162377
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-12-08
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT06162403
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Evaluation of Hereditary Cancer Educational Videos
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-12-06
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 74
- Registration Number
- NCT06157801
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
A Pilot Study for Pupillary Assessment to Predict CAR-T Related Neurotoxicity
Recruiting
- Conditions
- First Posted Date
- 2023-11-22
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT06144151
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination with the PARP Inhibitor Olaparib in Patients with KRAS G12C Mutated Advanced Solid Tumors, with a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-14
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 52
- Registration Number
- NCT06130254
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 1000
- Registration Number
- NCT06127797
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT06127121
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2024-05-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT06121232
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Phase 1B/2A Trial of Combination of ASTX727 With ASTX029 in Acute Myeloid Leukemia
- First Posted Date
- 2023-11-02
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 42
- Registration Number
- NCT06113289
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath